EUVIMEDEUVIMED entdecken
Crossref

Hypothalamic RASA1 /Ras/ AKT / GnRH axis reprogramming mediates GLP ‐ 1RA 's central rescue of PCOS HPG dysfunction

Linlin Yang, Na Guo, Xing Wang, Xincheng Zhang, Jinhong He, Hongyun Li, Huanhuan Zhou, Huijuan Ma iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Linlin Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Data Management Department, the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Gonadotropin-Releasing Hormone, Hypothalamus, Hypothalamo-Hypophyseal System. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, Government Funded Program for Clinical Medicine Talent Training Project of Hebei, Hebei Province High-level Talent Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Polycystic ovary syndrome (PCOS), characterised by hyperandrogenaemia and hypothalamic–pituitary–gonadal (HPG) axis dysregulation driven by gonadotropin‐releasing hormone (GnRH) neuronal hyperactivity, remains mechanistically enigmatic, with limited targeted therapies. Although glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) show potential in alleviating PCOS reproductive dysfunction, their presumed mechanisms have been confined to peripheral metabolic modulation. Materials and Methods Using liraglutide as a representative GLP‐1RA, this study elucidated the central control mechanism mediating GLP‐1RA's therapeutic effects in PCOS through systematically scanning hypothalamic protein profiles combined with pharmacology gain‐/loss‐of‐function experiments.

Results

In letrozole‐induced PCOS rats, GLP‐1RA administration significantly reduced serum testosterone and luteinizing hormone levels, partially restored oestrous cyclicity, and ameliorated ovarian follicular abnormalities. Hypothalamic proteomic mapping revealed that GLP‐1RA counteracts hyperandrogenism‐induced signalling perturbations, with network analysis identifying RASA1 as the critical hub connecting therapeutic responses to GnRH regulation. Mechanistically, RASA1 exerts dual control over GnRH neurons—directly suppressing GnRH biosynthesis while modulating Ras/AKT signalling dynamics. Notably, hypothalamic RASA1's effect on regulating ovarian functions and hormone homeostasis was confirmed by an AAV‐based in vivo experiment. Crucially, genetic and pharmacological interventions (RASA1 overexpression/AKT inhibition vs. RASA1 knockdown/AKT activation) reciprocally mimicked testosterone‐induced GnRH hypersecretion and GLP‐1RA‐mediated GnRH suppression, respectively, establishing causal relationships within this signalling axis.

Conclusion

Our findings provide the first evidence of GLP‐1RA's central mechanism in PCOS management, positioning the hypothalamic RASA1/Ras/AKT/GnRH axis as a master regulator of HPG axis homeostasis and unveiling novel therapeutic targets for precision intervention in reproductive neuroendocrinology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeGonadotropin-Releasing HormoneHypothalamusHypothalamo-Hypophyseal SystemFemaleAnimalsRatsLiraglutideProto-Oncogene Proteins c-aktSignal TransductionGlucagon-Like Peptide-1 Receptor AgonistsRats, Sprague-DawleyLetrozoleHyperandrogenismTestosterone

Stichwörter der Autor:innen

GLP‐1RAGnRHRASA1hypothalamuspolycystic ovary syndrome

Substanzen

Gonadotropin-Releasing HormoneLiraglutideProto-Oncogene Proteins c-aktGlucagon-Like Peptide-1 Receptor AgonistsLetrozoleTestosterone

Autor:innen und Institutionen

  • Endocrinology Department, Data Management Department, the First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Clinical Medical Research Center, Hebei General Hospital, Shijiazhuang, Hebei, China.

ORCID-Profile: Huijuan Ma

Förderung

  • Natural Science Foundation of Hebei Province
  • Government Funded Program for Clinical Medicine Talent Training Project of Hebei
  • Hebei Province High-level Talent Support Program

Zitieren

APA

Yang, L., Guo, N., Wang, X., Zhang, X., He, J., Li, H., Zhou, H., & Ma, H. (2026). Hypothalamic RASA1 /Ras/ AKT / GnRH axis reprogramming mediates GLP ‐ 1RA 's central rescue of PCOS HPG dysfunction. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70256

Vancouver

Yang L, Guo N, Wang X, Zhang X, He J, Li H, et al. Hypothalamic RASA1 /Ras/ AKT / GnRH axis reprogramming mediates GLP ‐ 1RA 's central rescue of PCOS HPG dysfunction. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70256

BibTeX
@article{Yang2026,
  author = {Yang, Linlin and Guo, Na and Wang, Xing and Zhang, Xincheng and He, Jinhong and Li, Hongyun and Zhou, Huanhuan and Ma, Huijuan},
  title = {Hypothalamic RASA1 /Ras/ AKT / GnRH axis reprogramming mediates GLP ‐ 1RA 's central rescue of PCOS HPG dysfunction},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70256}
}
Kostenlos starten →